Drug Shortage Report for MEPRON
| Report ID | 240697 |
| Drug Identification Number | 02217422 |
| Brand name | MEPRON |
| Common or Proper name | Atovaquone Oral Suspension |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ATOVAQUONE |
| Strength(s) | 750MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 210 ML |
| ATC code | P01AX |
| ATC description | AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DIS. |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2024-10-16 |
| Estimated end date | |
| Actual end date | 2024-11-21 |
| Shortage status | Resolved |
| Updated date | 2024-11-22 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2024-11-22 | French | Compare |
| v3 | 2024-11-22 | English | Compare |
| v2 | 2024-10-18 | French | Compare |
| v1 | 2024-10-18 | English | Compare |
Showing 1 to 4 of 4